ArticleAnnals of pancreatic cancer2020

Preclinical mouse models for immunotherapeutic and non-immunotherapeutic drug development for pancreatic ductal adenocarcinoma.

Mengni He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.